1Board T, Board R. The Role of 5 - HT sub3 Receptor Antagonists in Preventing Postoperative Nausea and Vomiting. Association of Operating Room Nurses. AORN Journal ,2006 ;83:209 -217
3Jorn H,Jim M,Koeller, et al.Acute emesis:moderately emetogenic chemotherapy[J].Support Care In Cancer,2010,13(2):951-955.
4National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology.Antiemesis.V.4.2009[M].USA Washington:National Comprehensive Cancer Network,2009:AE-7.
5Cleeland CS,Mendoza TR,Wang XS,et al.Assessing symptom distress in cancer patients:the M.D.Anderson Symptom Inventory[J].Cancer,2000,89(7):1634-1646.
6Tian W,Wang Z,Zhou J,et al.Randomized,double-blind,crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population[J].Med Oncol,2011,28(1):71-78.
7Tsukuda M,Ishitoya J,Mikami Y,et al.Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer:dexamethasone dosage verification trial[J].Int J Clin Oncol,2009,14(4):337-343.
